Global Intrauterine Contraceptive Device Market to Grow at a CAGR of 10% by 2023 - 99% Effective in Preventing Unwanted Pregnancy - Research and Markets

DUBLIN--()--The "Global Intrauterine Contraceptive Device Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023" report has been added to Research and Markets' offering.

The global intrauterine contraceptive device market is expected to rise at a CAGR of 10% during the forecast period 2016-2023. Intrauterine contraceptive devices are a form of long lasting reversible method for birth control. They are 99% effective in preventing unwanted pregnancy, convenient to use, are reversible and starts working immediately after installation. Due to these advantages, intrauterine contraceptive devices are used by large number of women across the world.

North America is the largest market region for intrauterine contraceptive device market owing to the increased adoption of these devices in United States. There is high rate of unplanned pregnancies among the teenagers in the U.S. Moreover, increasing number of initiatives taken by the U.S. government has helped to reduce the rising number of unplanned pregnancies and abortions rate in United States.

Furthermore, many U.S. based private companies have also contributed and provided the solutions for issues during pregnancy which includes teenage pregnancies, maternal mortality, increasing number of abortions etc., by promoting the advantages and use of intrauterine contraceptive devices. Furthermore, Asia Pacific is expected to emerge as the fastest increasing market owing to the presence of leading pharmaceutical companies in Asia Pacific countries such as China, Japan, India etc.

Companies Mentioned

  • Actavis Plc (U.S.)
  • Agile Therapeutics (U.S.)
  • Allergan, Plc (Ireland)
  • Bayer Healthcare Ag (U.S.)
  • Dkt International (U.S.)
  • Johnson & Johnson, Ltd (U.S.)
  • Lupin Pharmaceuticals, Ltd (India)
  • Medisafe Distribution, Inc. (Canada)
  • Meril Life Sciences Pvt. Ltd. (India)
  • Ocon Medical Ltd. (Israel)
  • Okamoto Industries, Inc. (Japan)
  • Pfizer (U.S.)
  • Smb Corporation (India)
  • Teva Pharmaceuticals Industries, Ltd (Israel)
  • Trimedic Supply Network Ltd (Canada)

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Competitive Landscape

6. Geographical Analysis

7. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/bht7bg/global

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Women's Health

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Women's Health